Analyst Reco. Vanda Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-07 pm EDT			5-day change	1st Jan Change
6.390 ^USD	-14.11%		-10.00%	-27.55%

May. 07	Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026
May. 06	Vanda Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Mar. 05	Truist Initiates Vanda Pharmaceuticals at Buy With $18 Price Target	MT
Feb. 25	B. Riley Adjusts Vanda Pharmaceuticals Price Target to $17 From $14, Maintains Buy Rating	MT
Dec. 31	B. Riley Raises Price Target on Vanda Pharmaceuticals to $14 Form $11, Keeps Buy Rating	MT
Nov. 05	B. Riley Initiates Coverage on Vanda Pharmaceuticals With Buy Rating, $11 Price Target	MT
25-07-31	Vanda Pharmaceuticals Q2 revenue up 4%	RE
24-10-31	HC Wainwright Starts Vanda Pharmaceuticals With Buy Rating, $18 Price Target	MT
24-07-11	Cantor Fitzgerald Initiates Vanda Pharmaceuticals at Overweight With $11 Price Target	MT
22-02-25	Jefferies Downgrades Vanda Pharmaceuticals to Hold From Buy, Adjusts Price Target to $12 From $24	MT
21-05-12	VANDA PHARMACEUTICALS : BofA Securities Starts Vanda Pharmaceuticals at Buy With $22 Price Target	MT
21-01-14	VANDA PHARMACEUTICALS : Citigroup Downgrades Vanda Pharmaceuticals to Neutral From Buy; Price Target is $14	MT